日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

帕博利珠单抗联合瘤内注射诺维梭菌-NT治疗晚期实体瘤患者的Ib期研究。

Nelson Blessie Elizabeth, Janku Filip, Fu Siqing, Dumbrava Ecaterina E, Hong David S, Karp Daniel D, Naing Aung, Rodon Jordi, Tsimberidou Apostolia M, Murthy Ravi, Sheth Rahul A, Amaria Rodabe N, Conley Anthony P, Damodaran Senthil, Raghav Kanwal P S, Carapanceanu Nicoleta, Singh Mahendra Pal, Carapanceanu Valentin, Pezeshki Abdulmohammad, Leontovich Alexey A, Kreider Brent L, Tung David, Varterasian Mary, Khazaie Khashayarsha, Piha-Paul Sarina A

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers

一项针对晚期实体瘤患者的 2 期篮式研究,评估了二肽基肽酶小分子抑制剂 talabostat 与 pembrolizumab 联合用药的疗效。

Ahmed, Jibran; Janku, Filip; Karp, Daniel D; Piha-Paul, Sarina A; Tsimberidou, Apostolia M; Yap, Timothy Anthony; Stephen, Bettzy; Yang, Yali; Gurses, Serdar; Liu, Qian; Song, Juhee; Meric-Bernstam, Funda; Naing, Aung

A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer

一项针对晚期或复发性子宫内膜癌患者的替西罗莫司联合二甲双胍的I期研究

Ahmed, Jibran; Stephen, Bettzy; Khawaja, Muhammad R; Yang, Yali; Salih, Israa; Barrientos-Toro, Elizve; Raso, Maria Gabriela; Karp, Daniel D; Piha-Paul, Sarina A; Sood, Anil K; Ng, Chaan S; Johnson, Amber; Soliman, Pamela T; Meric-Bernstam, Funda; Lu, Karen H; Naing, Aung

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial

来非托利莫德联合伊匹木单抗治疗晚期实体瘤患者:一项 I 期试验

Nardo, Mirella; Gouda, Mohamed A; Reilley, Matthew J; Biter, Amadeo B; Lim, Joann; Bean, Stacie A; Nguyen, Ly M; Bhosale, Priya R; Ager, Casey R; Couillault, Coline A; Piha-Paul, Sarina A; Fu, Siqing; Tsimberidou, Apostolia M; Yap, Timothy A; Naing, Aung; Rodon, Jordi; Subbiah, Vivek; Karp, Daniel D; Curran, Michael A; Hong, David S

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

塞利尼索联合免疫检查点阻断疗法治疗晚期肾细胞癌患者的 IB 期试验

Alhalabi, Omar; Gouda, Mohamed A; Milton, Denái R; Momin, Hassan Ahmed; Yilmaz, Bulent; Stephen, Bettzy; Ejezie, Chinenye Lynette; Moyers, Justin Tyler; Gurses, Serdar A; How, Jeffrey; Fu, Siqing; Rodon, Jordi; Hong, David S; Piha-Paul, Sarina A; Subbiah, Vivek; Elena Dumbrava, Ecaterina; Karp, Daniel D; Janku, Filip; Meric-Bernstam, Funda; Tannir, Nizar M; Naing, Aung

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study

更正:塞利尼索联合卡铂和紫杉醇治疗晚期实体瘤患者:一项单中心、多臂 Ib 期研究的结果

Thein, Kyaw Z; Karp, Daniel D; Tsimberidou, Apostolia; Gong, Jing; Sulovic, Selma; Shah, Jatin; Milton, Denái R; Hong, David S; Janku, Filip; McQuinn, Lacey; Stephen, Bettzy A; Colen, Rivka; Carter, Brett W; Yap, Timothy A; Piha-Paul, Sarina A; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung

Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies

BMS-986156联合伊匹木单抗或纳武利尤单抗,加或不加立体定向消融放射治疗,治疗晚期实体恶性肿瘤患者的I/II期研究

Chang, Joe Y; Xu, Xinyan; Shroff, Girish S; Comeaux, Nathan I; Li, Wei; Rodon Ahnert, Jordi; Karp, Daniel D; Dumbrava, Ecaterina E; Verma, Vivek; Chen, Aileen; Welsh, James; Hong, David S

Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations

针对伴有 BRCA1/2、DNA 修复和 PTEN 改变的晚期癌症,对 talazoparib 进行 II 期研究

Piha-Paul, Sarina A; Tseng, Chieh; Leung, Cheuk Hong; Yuan, Ying; Karp, Daniel D; Subbiah, Vivek; Hong, David; Fu, Siqing; Naing, Aung; Rodon, Jordi; Javle, Milind; Ajani, Jaffer A; Raghav, Kanwal P; Somaiah, Neeta; Mills, Gordon B; Tsimberidou, Apostolia M; Zheng, Xiaofeng; Chen, Ken; Meric-Bernstam, Funda

Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer Types

不同癌症类型中DNA错配修复基因的基因组改变

Holla, Vijaykumar R; Kahle, Michael P; Kim, Sun-Hee; Ronaghy, Arash; Yang, Richard K; Patel, Keyur P; Routbort, Mark J; Overman, Michael J; Dumbrava, Ecaterina E; Mills Shaw, Kenna R; Karp, Daniel D; Meric-Bernstam, Funda

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

Tinengotinib (TT-00420)(一种多激酶抑制剂)作为单药治疗晚期实体瘤患者的首次人体I期研究

Piha-Paul, Sarina A; Xu, Binghe; Dumbrava, Ecaterina E; Fu, Siqing; Karp, Daniel D; Meric-Bernstam, Funda; Hong, David S; Rodon, Jordi A; Tsimberidou, Apostolia M; Raghav, Kanwal; Ajani, Jaffer A; Conley, Anthony P; Mott, Frank; Fan, Ying; Fan, Jean; Peng, Peng; Wang, Hui; Ni, Shumao; Sun, Caixia; Qiang, Xiaoyan; Levin, Wendy J; Ngo, Brenda; Ru, Qinhua Cindy; Wu, Frank; Javle, Milind M